Last reviewed · How we verify
NCT03117686
Lung Ultrasound in High Altitude Lung Edema
trial testing lung ultrasound in Pulmonary Edema in 20 participants. Completed in 30 November 2017.
22 June 2017
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 10 June 2017 |
| Primary completion | 22 June 2017 |
| Estimated completion | 30 November 2017 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- lung ultrasound
Conditions studied
- Pulmonary Edema — all drugs for Pulmonary Edema →
Sponsor
Medical University of Vienna
Who can join
Adults 18 to 99, any sex, with Pulmonary Edema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High altitude pulmonary edema is a life-threatening condition that remains a concern for climbers and clinicians alike. It is defined as a non-cardiac pulmonary edema occurring at altitudes exceeding 3000m in non-acclimatised individuals. Recently, studies conducted in remote areas have demonstrated that ultrasound lung comets (B lines) can be used as a measure of sub-acute pulmonary edema and high altitude pulmonary edema in climbers ascending to altitude. the investigators want to assess the occurrence of of comet tails (B lines) as a measure of pulmonary edema among patients after lung transplantation and healthy individuals during an expedition to Mount Kilimanjaro.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03117686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of lung ultrasound
Trials testing the same drug.
- NCT07381790 — Modern Technologies in Lower Respiratory Tract Infections in Children · recruiting
- NCT06498895 — Lung Ultrasound Score as Post Operative Predictive Value of Pulmonary Complications in Living Liver Transplant Recipient · not yet recruiting
- NCT06950112 — Comparison Between Individualized PEEP Ventilation Guided by Driving Pressure and Conventional Lung Protective Strategy · NA · recruiting
- NCT06550219 — Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound · NA · recruiting
- NCT06443528 — Comparison of Lung Ultrasound Scores With Clinical Models for Predicting Bronchopulmonary Dysplasia：A Multi-center Prosp · not yet recruiting
Other recruiting trials for Pulmonary Edema
Currently open trials in the same condition.
- NCT05276219 — Optimized Treatment of Pulmonary Edema or Congestion · Phase 4 · recruiting
- NCT05227222 — PEP-device for Treatment of Swimming-induced Pulmonary Edema (SIPE) · NA · recruiting
- NCT04307615 — O2 Versus CPAP Treatment of Patients Undergoing SIPE Therapy (OCTOPUS) · NA · recruiting
- NCT04115514 — Treatment of ARDS With Instilled T3 · Phase 2 · active not recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03117686 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 2 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03117686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing